FREMONT, Calif., Oct. 18 /PRNewswire-FirstCall/ -- Abgenix, Inc.
(Nasdaq: ABGX) will announce third quarter financial results on Tuesday,
October 25, 2005, after the close of financial markets. Following the
announcement, Abgenix will host a conference call at 1:30 p.m. Pacific Time to
review the company's financial results and product developments.
The live and archived webcasts of the conference call will be available on
the Abgenix website, http://www.abgenix.com. To participate in the conference call,
please dial 866-700-7441 or 617-213-8839 fifteen minutes before start time.
The pass code for the live call is 74073994. A telephonic replay of the call
will be available through November 8, 2005 by dialing 888-286-8010 or
617-801-6888. The replay participant code is 87765844.
About Abgenix
Abgenix is a biopharmaceutical company focused on the discovery,
development and manufacturing of fully human therapeutic antibodies. The
company's antibody development platform includes a leading antibody technology
and state-of-the-art manufacturing capabilities that enable the rapid
generation, selection and production of high affinity antibodies with the
potential to target disease. Abgenix leverages its leadership position in
human antibody technology to build a diversified product portfolio through its
own development efforts and the establishment of collaborations with multiple
pharmaceutical and biotechnology companies. For more information on Abgenix,
visit the company's website at http://www.abgenix.com.
SOURCE Abgenix, Inc.
 back to top
Related links:
http://www.abgenix.com
CONTACT:
Greg Mann, Director, Corporate Communications
& Investor Relations, of Abgenix, Inc., +1-510-284-6566
|
